Monogram Health, the leading multi-specialty provider of in-home, evidence-based care for patients with multiple chronic conditions, was selected as a “Fierce 15” healthcare company for 2026 by Fierce Healthcare. The annual recognition features the most innovative, private healthcare companies transforming the industry. Monogram was selected for its ability to revolutionize treatment and care delivery for America’s most complex patient population.
Integrated Care Model
Since 2019, Monogram has redefined integrated care by bridging the gap between those who pay for care (insurers), those who deliver care (providers and clinicians), and those living with the outcome (patients). The company’s model aligns clinical action, financial responsibility, and human impact within one ecosystem. According to CEO and Co-Founder Michael Uchrin, “Monogram brings personalized, specialist-level treatment directly to a patient’s home, offering concierge-style care not to those that can afford it, but to those that need it most.”
Clinical Outcomes
The current healthcare system provides fragmented, organ-by-organ treatment with gaps in pharmacological, social, and behavioral health needs. Monogram’s interdisciplinary approach deploys an employed workforce of multispecialty-trained clinicians—physicians, advanced practice providers, nurses, pharmacists, dieticians, social workers, and specialists—that simultaneously evaluate and treat the whole person in the home setting. At the end of 2025, of Monogram’s patient population of about 200,000, 88.5% had their A1C under control, 78.3% had their blood pressure under control, and 87.5% had a comprehensive medication review in the last year. The company addressed more than 35,000 socioeconomic gaps.
Health System Impact
These results enabled a 52% reduction in ER visits and 44% fewer hospital admissions, equating to more than $375 million in medical cost savings. This improved affordability for patients in 2025. Monogram is based in Nashville, Tennessee, operates throughout much of the U.S., and is privately held by Frist Cressey Ventures, Norwest Venture Partners, TPG Capital, and other leading investors. Inc. Magazine ranked Monogram as the 3rd fastest growing private company in the U.S. in 2024 and 7th in 2025.
This article is an AI-assisted summary. All facts and figures are drawn from the original report: https://www.globenewswire.com/news-release/2026/03/10/3253151/0/en/Monogram-Health-Named-A-Fierce-15-Company-for-2026-by-Healthcare-Media-Conglomerate-Fierce-Healthcare.html